Access Statistics for Neeraj Sood

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Back to School: The Effect of School Visits During COVID-19 on COVID-19 Transmission 0 0 1 13 0 0 5 57
Conforming and Non-conforming Peer Effects in Vaccination Decisions 0 0 0 31 0 0 1 73
Criminal Prosecution and HIV-related Risky Behavior 0 0 0 27 2 2 3 253
Disadvantaging Rivals: Vertical Integration in the Pharmaceutical Market 0 1 3 26 0 2 11 32
Do “Consumer-Directed” Health Plans Bend the Cost Curve Over Time? 0 0 0 25 0 0 1 108
Does Health Insurance Make You Fat? 0 0 0 126 0 2 7 255
Does How Much and How You Pay Matter? Evidence from the Inpatient Rehabilitation Facility Prospective Payment System 0 0 0 25 0 0 0 182
Does The Market Reward Quality?: Evidence from India 0 0 1 37 0 0 2 28
Effects of Medicare Payment Reform: Evidence from the Home Health Interim and Prospective Payment Systems 1 1 1 2 1 1 2 67
Effects of Medicare Payment Reform: Evidence from the Home Health Interim and Prospective Payment Systems 0 0 0 16 0 0 2 74
Effects of Medicare Payment Reform: Evidence from the Home Health Interim and Prospective Payment Systems 0 0 1 19 0 0 3 99
Effects of Payment Reform in More versus Less Competitive Markets 0 0 0 19 0 1 2 70
Employer-Sponsored Insurance, Health Care Cost Growth, and the Economic Performance of U.S. Industries 0 0 0 4 0 0 1 45
Federal Life Sciences Funding and University R&D 0 0 0 47 2 2 9 232
Financial Risk Protection from Social Health Insurance 0 0 2 80 0 1 4 99
HIV Breakthroughs and Risk Sexual Behavior 0 0 0 84 1 1 1 635
Health Insurance and the Obesity Externality 0 0 1 203 0 0 1 897
Health Insurance as a Two-Part Pricing Contract 0 0 0 97 1 2 4 426
Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data 0 0 0 52 0 0 0 191
Identifying the Health Production Function: The Case of Hospitals 0 0 2 69 0 2 17 418
Insurance and Innovation in Health Care Markets 0 0 2 138 1 1 3 468
Market Evidence of Misperceived Prices and Mistaken Mortality Risks 0 0 0 51 0 1 1 292
Mortality Risks, Health Endowments, and Parental Investments in Infancy: Evidence from Rural India 0 0 0 37 0 0 1 148
Patient Responses to Incentives in Consumer-directed Health Plans: Evidence from Pharmaceuticals 0 0 0 35 0 0 0 47
Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D 0 0 1 24 0 0 1 96
Projected Health Benefits and Health Care Savings from the United States National Hepatitis C Elimination Initiative 0 0 0 13 1 1 4 20
Technology, Monopoly, and the Decline of the Viatical Settlements Industry 0 0 0 77 1 1 1 717
The Effect of Prospective Payment on Admission and Treatment Policy: Evidence from Inpatient Rehabilitation Facilities 0 0 0 15 0 0 0 123
The Ex-Ante Moral Hazard Effects of COVID-19 Vaccines 0 0 1 7 1 3 5 24
The Impact of Direct-to-Consumer Advertising on Outpatient Care Utilization 0 0 0 18 0 0 0 10
The Impact of Insurance and HIV Treatment Technology on HIV Testing 0 0 0 25 0 3 3 71
The Impact of Medicare Part D on Pharmaceutical R&D 0 0 0 80 0 0 5 357
The Impact of the COVID-19 Pandemic and Policy Response on Health Care Utilization: Evidence from County-level Medical Claims and Cellphone data 0 0 1 17 1 3 4 88
The Impact of the COVID-19 Pandemic and Policy Responses on Excess Mortality 0 1 2 17 0 1 3 121
The Impact of the COVID-19 Vaccine Distribution on Mental Health Outcomes 0 0 0 24 0 0 7 83
The Impact of the Global COVID-19 Vaccination Campaign on All-Cause Mortality 0 0 0 2 0 1 4 12
The Link Between Public and Private Insurance and HIV-Related Mortality 0 0 0 79 0 3 3 486
The Reallocation of Compensation in Response to Health Insurance Premium Increases 0 0 0 52 0 0 3 338
The Welfare Effects of Public Drug Insurance 0 0 0 77 1 1 2 287
Wage and Benefit Changes in Response to Rising Health Insurance Costs 0 0 0 54 0 0 1 294
Total Working Papers 1 3 19 1,844 13 35 127 8,323


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Adverse Selection in Retiree Prescription Drug Plans 0 0 0 15 0 0 1 101
Criminal Prosecution and Human Immunodeficiency Virus-Related Risky Behavior 0 0 0 8 0 0 0 96
Do People Taking Flu Vaccines Need Them the Most? 0 0 0 0 0 0 0 2
Do Physicians Respond to the Costs and Cost-Sensitivity of Their Patients? 0 0 0 4 0 0 3 59
Do Statins Reduce the Health and Health Care Costs of Obesity? 0 0 2 7 1 2 6 32
Do companies in the pharmaceutical supply chain earn excess returns? 0 0 0 12 0 0 0 44
Do “Consumer-Directed” health plans bend the cost curve over time? 0 0 0 19 0 0 1 123
Does how much and how you pay matter? Evidence from the inpatient rehabilitation care prospective payment system 0 0 0 18 0 0 2 74
Does the market reward quality? Evidence from India 0 0 0 0 0 0 0 2
Effects of Medicare payment reform: Evidence from the home health interim and prospective payment systems 0 0 0 22 1 2 4 184
Effects of employer-offered high-deductible plans on low-value spending in the privately insured population 0 0 0 1 1 1 3 13
Effects of payment reform in more versus less competitive markets 0 0 1 4 0 1 2 35
Evaluation of a COVID-19 rapid antigen testing program among student athletes in a public high school district 0 0 0 0 0 1 1 1
Financial risk protection from social health insurance 0 0 1 24 0 0 4 120
Firm-Level Perspectives on Public Sector Engagement with Private Healthcare Providers: Survey Evidence from Ghana and Kenya 0 0 1 1 0 0 2 4
Government health insurance and spatial peer effects: New evidence from India 0 0 0 10 1 1 2 43
HIV Breakthroughs and Risky Sexual Behavior 0 0 0 166 1 1 3 912
HIV-related social intolerance and risky sexual behavior in a high HIV prevalence environment 0 0 0 6 0 0 0 25
Health insurance as a two-part pricing contract 0 0 0 49 0 0 1 358
Healthy Firms: Constraints to Growth among Private Health Sector Facilities in Ghana and Kenya 0 0 0 1 1 2 2 6
How Do Consumer-Directed Health Plans Affect Vulnerable Populations? 0 0 0 24 0 1 2 226
Innovation and the welfare effects of public drug insurance 1 1 2 44 1 1 6 156
Luck of the draw: Role of chance in the assignment of medicare readmissions penalties 0 0 0 0 0 0 0 4
Market evidence of misperceived mortality risk 0 0 0 10 0 0 0 32
Market power and state costs of HIV/AIDS drugs 0 0 0 35 0 0 0 141
Market size and innovation: Effects of Medicare Part D on pharmaceutical research and development 0 2 5 78 1 4 21 349
New Evidence on Hospital Profitability by Payer Group and the Effects of Payer Generosity 0 0 0 213 0 0 1 601
Optimal contributions to flexible spending accounts 0 0 0 20 1 1 2 79
Pharmaceutical advertising and Medicare Part D 0 0 0 12 1 1 2 147
Prescription drug advertising and drug utilization: The role of Medicare Part D 0 0 1 2 1 1 5 13
Price Regulation in Secondary Insurance Markets 0 0 0 13 0 0 1 82
Price Shopping in Consumer-Directed Health Plans 0 0 0 7 0 0 0 70
Private Sector Participation and Health System Performance in Sub-Saharan Africa 0 0 0 0 1 1 1 2
Productivity growth of skilled nursing facilities in the treatment of post-acute-care-intensive conditions 0 0 0 0 1 1 4 4
Quantifying the Value of Personalized Medicines: Evidence from COX-2 Inhibitors 0 0 0 10 0 0 0 68
Social insurance and the design of innovation incentives 0 0 0 20 0 0 2 87
The Effect of State Cost Containment Strategies on the Insurance Status and Use of Antiretroviral Therapy (HAART) for HIV Infected People 0 0 0 6 0 0 0 107
The Effects of Consumer-Directed Health Plans on Episodes of Health Care 0 0 0 32 0 0 4 99
The Impact of Insurance on HIV Testing 0 0 0 3 0 0 2 23
The Impact of Insurance on HIV Testing 0 0 0 14 1 1 1 100
The Short and Long Run Effects of Daylight Saving Time on Fatal Automobile Crashes 0 0 3 87 0 2 7 388
The Value of Diagnostic Testing in Personalized Medicine 0 0 0 60 0 0 0 218
The effect of federal research funding on formation of university-firm biopharmaceutical alliances 0 0 1 7 1 1 4 53
The effect of prospective payment on admission and treatment policy: Evidence from inpatient rehabilitation facilities 0 0 0 14 0 0 3 154
The impact of COVID‐19 shelter‐in‐place policy responses on excess mortality 0 0 1 1 0 0 3 4
The impact of the COVID-19 pandemic and policy response on health care utilization: Evidence from county-level medical claims and cellphone data 0 0 1 7 1 2 5 19
The link between public and private insurance and HIV-related mortality 0 0 0 33 0 0 1 298
The long term effects of “Consumer-Directed” health plans on preventive care use 0 0 0 6 0 0 0 33
The reallocation of compensation in response to health insurance premium increases 0 0 1 13 0 0 6 164
University R&D Funding Strategies in a Changing Federal Funding Environment 0 0 0 2 0 0 0 33
WHY MEDICARE PRICE NEGOTIATION IS THE WRONG PRESCRIPTION FOR RISING DRUG SPENDING 0 0 0 7 1 1 2 20
WHY MEDICARE PRICE NEGOTIATION IS THE WRONG PRESCRIPTION FOR RISING DRUG SPENDING: RESPONSE TO RENA CONTI 0 0 0 17 1 1 2 48
Wage and Benefit Changes in Response to Rising Health Insurance 0 0 0 21 0 0 0 123
Who Pays for Obesity? 0 0 0 72 0 3 7 316
Total Journal Articles 1 3 20 1,257 18 33 131 6,495


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Adverse Selection in Retiree Prescription Drug Plans 0 0 0 0 0 0 0 29
Does Health Insurance Make You Fat? 0 1 1 39 0 3 10 194
Health Insurance and the Obesity Externality 0 0 2 2 1 2 7 12
Patents, innovation, and the welfare effects of Medicare Part D 0 0 0 0 0 1 1 1
Quantifying Productivity Growth in the Delivery of Important Episodes of Care within the Medicare Program Using Insurance Claims and Administrative Data 0 0 0 4 0 0 1 31
Wage and Benefit Changes in Response to Rising Health Insurance 0 0 0 0 1 1 2 40
Total Chapters 0 1 3 45 2 7 21 307


Statistics updated 2025-03-03